Patients choose their own treatment in landmark myelofibrosis study
NCT ID NCT04217356
First seen Jan 06, 2026 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study compares a stem cell transplant to the best available non-transplant treatments for people with high-risk myelofibrosis, a serious bone marrow cancer. About 90 participants will choose which treatment they prefer, and researchers will track survival and quality of life over time. The goal is to see which approach offers better outcomes for this challenging condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cross Cancer Institute
Edmonton, Alberta, T6G2G3, Canada
-
Nova Scotia Health Authority
Halifax, Nova Scotia, B3H2Y9, Canada
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G2M9, Canada
-
St. Paul's Hospital
Vancouver, British Columbia, V6E1M7, Canada
-
Tom Baker Cancer Centre
Calgary, Alberta, T2N4N2, Canada
Conditions
Explore the condition pages connected to this study.